Subacute Thyroiditis During the SARS-CoV-2 Pandemic.
SAT
thyroid
thyroid dysfunction
thyroiditis
viruses
Journal
Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
10
06
2021
entrez:
30
8
2021
pubmed:
31
8
2021
medline:
31
8
2021
Statut:
epublish
Résumé
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been related to subacute thyroiditis (SAT). We compared SAT cases during the SARS-CoV-2 pandemic to those observed in the previous years. A cross-sectional, retrospective study was conducted at the Endocrinology Unit of University Hospital of Pisa, Italy. We included all patients observed from January 2016 to December 2020 because of an untreated SAT, who had developed the disease within 15 days prior to the visit. SAT cases from 2016 to 2019 (N = 152) are referred to as While during 2016-2019, most SAT cases were observed in the third quarter, in 2020, 2 peaks were seen, superimposable to the SARS-CoV-2 outbreaks in the second and the fourth quarters. In the second and fourth quarters of 2020, we observed higher levels of free thyroxine (FT4), C-reactive protein (CRP), and thyroglobulin (Tg) compared with the same quarters of the years 2016-2019. Pos-SARS-CoV-2 patients had higher FT4 (28.4 vs 24.1 nmol/L), CRP (8.5 vs 3.6 mg/L), and Tg (155 vs 60 µg/L) ( The SARS-CoV-2 pandemic has caused a shift in the annual timing and severity of SAT cases.
Identifiants
pubmed: 34458656
doi: 10.1210/jendso/bvab130
pii: bvab130
pmc: PMC8344892
doi:
Types de publication
Journal Article
Langues
eng
Pagination
bvab130Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
Références
J Endocrinol Invest. 2020 Aug;43(8):1171-1172
pubmed: 32488726
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
J Clin Endocrinol Metab. 1995 Dec;80(12):3653-6
pubmed: 8530615
BMJ Case Rep. 2020 Aug 25;13(8):
pubmed: 32843467
Case Rep Endocrinol. 2020 Sep 28;2020:8891539
pubmed: 33005461
J Endocrinol Invest. 2012 Sep;35(8):712-4
pubmed: 23014133
Thyroid. 2018 Mar;28(3):288-294
pubmed: 29439614
Heart Lung Circ. 2020 Jul;29(7):973-987
pubmed: 32601020
J Clin Endocrinol Metab. 2020 Oct 1;105(10):
pubmed: 32780854
Med Microbiol Immunol. 1975;161(2):133-44
pubmed: 806773
Thyroid. 2016 Oct;26(10):1343-1421
pubmed: 27521067
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 32436948
Intern Med. 2008;47(8):725-9
pubmed: 18421188
J Clin Endocrinol Metab. 2020 Jun 1;105(6):
pubmed: 31996918
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Intern Med J. 2021 Jun 17;:
pubmed: 34139048
Eur Thyroid J. 2019 Oct;8(5):268-272
pubmed: 31768338
Lancet Diabetes Endocrinol. 2020 Sep;8(9):739-741
pubmed: 32738929
J Endocrinol Invest. 1987 Jun;10(3):321-3
pubmed: 3624803
Am J Med Sci. 2021 Mar;361(3):400-402
pubmed: 33097194
Virol J. 2009 Jan 12;6:5
pubmed: 19138419
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
Hormones (Athens). 2021 Mar;20(1):219-221
pubmed: 32676935
Eur J Endocrinol. 2020 Oct;183(4):381-387
pubmed: 32698147
Eur Thyroid J. 2021 Feb;9(6):321-323
pubmed: 33708633